<scp>SARS‐CoV</scp> ‐2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey-Reference-Cited by-同舟云学术

SARS‐CoV ‐2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey

Published:2022-03-26 Issue:7 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Giannotta Juri Alessandro¹^ORCID,Fattizzo Bruno¹²,Bortolotti Marta¹²,Girmenia Corrado³^ORCID,Ielo Claudia⁴,Metafuni Elisabetta⁵⁶^ORCID,Visentin Adele⁷,Apolito Vincenzo⁸,Lucchesi Alessandro⁹^ORCID,Giai Valentina⁸,Beggiato Eloise⁸,Di Bona Eros⁷,Giglio Fabio¹⁰,Sica Simona⁵⁶,Iori Anna Paola³,Barcellini Wilma¹^ORCID

Affiliation:

1. Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

2. Department of Oncology and Oncohematology University of Milan Milan Italy

3. Department of Haematology, Oncology and Dermatology “Umberto I” University Hospital, Roma Sapienza University Rome Italy

4. Hematology, Department of Translational and Precision Medicine Sapienza University Policlinico Umberto I Rome Italy

5. Istituto di Ematologia, Policlinico Universitario A Gemelli IRCCS Università Cattolica del Sacro Cuore Rome Italy

6. Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

7. Hematology Department UOC Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa Vicenza Italy

8. Department of Oncology, Division of Hematology AOU Città della Salute e della Scienza di Torino, Presidio Molinette Turin Italy

9. Hematology Unit IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Meldola Italy

10. Hematology and Bone Marrow Transplant Unit IRCCS San Raffaele Scientific Institute Milan Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26545

Reference7 articles.

1. COVID‐19 infection in patients on anti‐complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience

2. How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry

3. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

4. COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria

5. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2;Blood Reviews;2023-07

2. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs;Blood Reviews;2023-03

3. Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation;eJHaem;2022-09-28

4. Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria;Japanese Journal of Thrombosis and Hemostasis;2022